Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 10/20 | 0.48 |
| ▸ | PDE4B | Q07343 | 10/20 | 0.48 |
| ▸ | PDE4C | Q08493 | 10/20 | 0.48 |
| ▸ | PDE4D | Q08499 | 10/20 | 0.48 |
| ▸ | ADORA2B | P29275 | 9/20 | 0.48 |
| ▸ | ADORA2A | P29274 | 6/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6381756 | 0.84 | PDE1A (0.61) | ADORA2BSMN1; SMN2 | |
| SCHEMBL2957435 | 0.83 | PDE4A (0.48) | PDE4APDE4BPDE4CPDE4DADORA2B | |
| SCHEMBL6383651 | 0.83 | KMT2A (0.37) | PDE4APDE4BPDE4CPDE4DADORA2B | |
| SCHEMBL6380596 | 0.78 | SMN1; SMN2 (0.44) | PDE4APDE4BPDE4CPDE4DADORA2B | |
| SCHEMBL6381931 | 0.75 | RXFP1 (0.40) | PDE4APDE4BPDE4CPDE4DADORA2B | |
| SCHEMBL5771868 | 0.74 | TRPA1 (0.41) | PDE4APDE4BPDE4CPDE4DADORA2B | |
| SCHEMBL5790131 | 0.71 | TRPA1 (0.38) | PDE4APDE4BPDE4CPDE4DADORA2B | |
| SCHEMBL6381646 | 0.71 | PDE4A (0.59) | PDE4APDE4BPDE4CPDE4DADORA2B | |
| SCHEMBL6383655 | 0.71 | PDE4A (0.35) | PDE4APDE4BPDE4CPDE4DADORA2B | |
| SCHEMBL28319203 | 0.69 | ADORA2B (0.56) | PDE4APDE4BPDE4CPDE4DADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1557165-A1 | COMBINATION DRUG | Eisai Co., Ltd. (JP) | 2005-07-27 | — | — | EP | disclosed |